Literature DB >> 27701509

Piracetam for the treatment of sickle cell disease in children- a double blind test.

Mohsen A F El-Hazmi1, I Al-Fawaz, A Warsy, A Opawoye, H Taleb, Z Howsawi, A Mohamed, A Wadood Aly, S Refai, P Sugathan, A Rab, H Ahmed, M Abulaban, A Abdulkader, M Farid.   

Abstract

Full text is available as a scanned copy of the original print version.

Entities:  

Year:  1998        PMID： 27701509

Source DB:  PubMed          Journal:  Saudi Med J        ISSN： 0379-5284            Impact factor:   1.484


  5 in total

Review 1.  Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review.

Authors:  Joep W R Sins; David J Mager; Shyrin C A T Davis; Bart J Biemond; Karin Fijnvandraat
Journal:  Blood Adv       Date:  2017-08-22

Review 2.  Piracetam for reducing the incidence of painful sickle cell disease crises.

Authors:  Amani Al Hajeri; Zbys Fedorowicz
Journal:  Cochrane Database Syst Rev       Date:  2016-02-12

Review 3.  Inhaled nitric oxide for acute chest syndrome in people with sickle cell disease.

Authors:  A Al Hajeri; G R Serjeant; Z Fedorowicz
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

4.  Blood transfusions for treating acute chest syndrome in people with sickle cell disease.

Authors:  Roya Dolatkhah; Saeed Dastgiri
Journal:  Cochrane Database Syst Rev       Date:  2020-01-16

5.  Drugs for preventing red blood cell dehydration in people with sickle cell disease.

Authors:  Srikanth Nagalla; Samir K Ballas
Journal:  Cochrane Database Syst Rev       Date:  2018-10-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.